IL17A and age-related macular degeneration: PBMCs extracted from AMD patients exhibit hypomethylation of the IL-17RC promoter has been reported in one study [70], which coincides with enhanced expression levels of both IL-17A and IL-17RC in AMD maculae when compared with both healthy maculae and the peripheral retinas of AMD-afflicted eyes [69].